Non-metastatic 2 (NME2)-mediated suppression of lung cancer metastasis involves transcriptional regulation of key cell adhesion factor vinculin

Nucleic Acids Research

Volumn 42, Issue 18, 2014, Pages 11589-11600

  Thakur, Ram Krishna ^a   Yadav, Vinod Kumar ^a   Kumar, Akinchan ^a   Singh, Ankita ^a,b   Pal, Krishnendu ^c   Hoeppner, Luke ^c   Saha, Dhurjhoti ^a,b   Purohit, Gunjan ^a,b   Basundra, Richa ^a   Kar, Anirban ^a   Halder, Rashi ^a   Kumar, Pankaj ^a,b   Baral, Aradhita ^a   Kumar, M J Mahesh ^d   Baldi, Alfonso ^e   Vincenzi, Bruno ^f   Lorenzon, Laura ^g   Banerjee, Rajkumar ^h   Kumar, Praveen ^a   Shridhar, Viji ⁱ   Mukhopadhyay, Debabrata ^c   Chowdhury, Shantanu ^a,b   more..

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH ACSIR   (India)

^c MAYO GRADUATE SCHOOL   (United States)

^d CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^e SECOND UNIVERSITY OF NAPLES   (Italy)

^f UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

ⁱ MAYO CLINIC CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NON METASTATIC 2 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VINCULIN; NME2 PROTEIN, HUMAN; NUCLEOSIDE DIPHOSPHATE KINASE NM23;

A549 CELL LINE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FOCAL ADHESION; GENE EXPRESSION; GENE MAPPING; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS INHIBITION; METASTASIS POTENTIAL; MICROARRAY ANALYSIS; MOUSE; NON METASTATIC 2 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEPLETION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; ZEBRA FISH; ANIMAL; BIOSYNTHESIS; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; LUNG TUMOR; METABOLISM; MORTALITY; SECONDARY; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

DANIO RERIO; MUS MUSCULUS;

ANIMALS; CELL LINE, TUMOR; DISEASE PROGRESSION; FOCAL ADHESIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; MICE, NUDE; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC; VINCULIN; ZEBRAFISH;

EID: 84922354711     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku860     Document Type: Article

References (42)

1. Fidler, I.J. (2003). The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer, 3, 453-458
2. Hanahan, D. andWeinberg, R.A. (2011). Hallmarks of cancer: the next generation. Cell, 144, 646-674
3. Nguyen, D.X., Bos, P.D. and Massague, J. (2009). Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer, 9, 274-284
4. Gupta, G.P. and Massague, J. (2006). Cancer metastasis: building a framework. Cell, 127, 679-695
5. Rinker-Schaeffer, C.W., O'Keefe, J.P., Welch, D.R. and Theodorescu, D. (2006). Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application. Clin. Cancer Res., 12, 3882-3889
6. Horak, C.E., Lee, J.H., Marshall, J.C., Shreeve, S.M. and Steeg, P.S. (2008). The role of metastasis suppressor genes in metastatic dormancy. APMIS, 116, 586-601
7. Hurst, D.R. and Welch, D.R. (2011). Metastasis suppressor genes at the interface between the environment and tumor cell growth. Int. Rev. Cell Mol. Biol., 286, 107-180
8. Yoshida, B.A., Sokoloff, M.M., Welch, D.R. and Rinker-Schaeffer, C.W. (2000). Metastasis-suppressor genes: a review and perspective on an emerging field. J. Natl. Cancer Inst., 92, 1717-1730
9. Hoffman, P.C., Mauer, A.M. and Vokes, E.E. (2000). Lung cancer. Lancet, 355, 479-485
10. Siegel, R., Ward, E., Brawley, O. and Jemal, A. (2011). Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J. Clin., 61, 212-236
11. Takeuchi, T., Tomida, S., Yatabe, Y., Kosaka, T., Osada, H., Yanagisawa, K., Mitsudomi, T. and Takahashi, T. (2006). Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. J. Clin. Oncol., 24, 1679-1688
12. Shedden, K., Taylor, J.M., Enkemann, S.A., Tsao, M.S., Yeatman, T.J., Gerald, W.L., Eschrich, S., Jurisica, I., Giordano, T.J., Misek, D.E. et al. (2008). Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat. Med., 14, 822-827
13. Tomida, S., Takeuchi, T., Shimada, Y., Arima, C., Matsuo, K., Mitsudomi, T., Yatabe, Y. and Takahashi, T. (2009). Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis. J. Clin. Oncol., 27, 2793-2799
14. Steeg, P.S., Bevilacqua, G., Kopper, L., Thorgeirsson, U.P., Talmadge, J.E., Liotta, L.A. and Sobel, M.E. (1988). Evidence for a novel gene associated with low tumor metastatic potential. J. Natl. Cancer Inst., 80, 200-204
15. Hartsough, M.T. and Steeg, P.S. (2000). Nm23/nucleoside diphosphate kinase in human cancers. J. Bioenerg. Biomembr., 32, 301-308
16. Thakur, R.K., Yadav, V.K., Kumar, P. and Chowdhury, S. (2011). Mechanisms of non-metastatic 2 (NME2)-mediated control of metastasis across tumor types. Naunyn Schmiedebergs Arch. Pharmacol., 384, 397-406
17. Postel, E.H., Berberich, S.J., Flint, S.J. and Ferrone, C.A. (1993). Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Science, 261, 478-480
18. Postel, E.H., Berberich, S.J., Rooney, J.W. and Kaetzel, D.M. (2000). Human NM23/nucleoside diphosphate kinase regulates gene expression through DNA binding to nuclease-hypersensitive transcriptional elements. J. Bioenerg. Biomembr., 32, 277-284
19. Thakur, R.K., Kumar, P., Halder, K., Verma, A., Kar, A., Parent, J.L., Basundra, R., Kumar, A. and Chowdhury, S. (2009). Metastases suppressor NM23-H2 interaction with G-quadruplex DNA within c-MYC promoter nuclease hypersensitive element induces c-MYC expression. Nucleic Acids Res., 37, 172-183
20. Kar, A., Saha, D., Purohit, G., Singh, A., Kumar, P., Yadav, V.K., Kumar, P., Thakur, R.K. and Chowdhury, S. (2012). Metastases suppressor NME2 associates with telomere ends and telomerase and reduces telomerase activity within cells. Nucleic Acids Res., 40, 2554-2565
21. Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gillette, M.A., Paulovich, A., Pomeroy, S.L., Golub, T.R., Lander, E.S. et al. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A, 102, 15545-15550
22. Hoffman, P.C., Mauer, A.M. and Vokes, E.E. (2000). Lung cancer. Lancet, 355, 479-485
23. Nguyen, D.X., Chiang, A.C., Zhang, X.H., Kim, J.Y., Kris, M.G., Ladanyi, M., Gerald, W.L. and Massague, J. (2009). WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell, 138, 51-62
24. Wrage, M., Ruosaari, S., Eijk, P.P., Kaifi, J.T., Hollmen, J., Yekebas, E.F., Izbicki, J.R., Brakenhoff, R.H., Streichert, T., Riethdorf, S. et al. (2009). Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletion. Clin. Cancer Res., 15, 1566-1574
25. Lawrence, C.E., Altschul, S.F., Boguski, M.S., Liu, J.S., Neuwald, A.F. and Wootton, J.C. (1993). Detecting subtle sequence signals: a Gibbs sampling strategy for multiple alignment. Science, 262, 208-214
26. Kanehisa, M. and Goto, S. (2000). KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res., 28, 27-30
27. Mierke, C.T. (2009). The role of vinculin in the regulation of the mechanical properties of cells. Cell Biochem. Biophys., 53, 115-126
28. White, R., Rose, K. and Zon, L. (2013). Zebrafish cancer: the state of the art and the path forward. Nat. Rev. Cancer, 13, 624-636
29. Stoletov, K., Kato, H., Zardouzian, E., Kelber, J., Yang, J., Shattil, S. and Klemke, R. (2010). Visualizing extravasation dynamics of metastatic tumor cells. J. Cell Sci., 123, 2332-2341
30. Kedrin, D., van, R.J., Hernandez, L., Condeelis, J. and Segall, J.E. (2007). Cell motility and cytoskeletal regulation in invasion and metastasis. J. Mammary. Gland. Biol. Neoplasia., 12, 143-152
31. Ohta, Y., Nozawa, H., Tanaka, Y., Oda, M. and Watanabe, Y. (2000). Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer. J. Thorac. Cardiovasc. Surg., 119, 804-813
32. Ohta, Y., Nozaki, Z., Nozawa, H., Kamesui, T., Tsunezuka, Y., Oda, M. and Watanabe, G. (2001). The predictive value of vascular endothelial growth factor and nm23 for the diagnosis of occult metastasis in non-small cell lung cancer. Jpn. J. Cancer Res., 92, 361-366
33. Subramaniam, S., Thakur, R.K., Yadav, V.K., Nanda, R., Chowdhury, S. and Agrawal, A. (2013). Lung cancer biomarkers: state of the art. J. Carcinog., 13
34. Higashiyama, M., Doi, O., Yokouchi, H., Kodama, K., Nakamori, S., Tateishi, R. and Kimura, N. (1992). Immunohistochemical analysis of nm23 gene product/NDP kinase expression in pulmonary adenocarcinoma: lack of prognostic value. Br. J. Cancer, 66, 533-536
35. MacKinnon, M., Kerr, K.M., King, G., Kennedy, M.M., Cockburn, J.S. and Jeffrey, R.R. (1997). p53, c-erbB-2 and nm23 expression have no prognostic significance in primary pulmonary adenocarcinoma. Eur. J. Cardiothorac. Surg., 11, 838-842
36. Cervoni, L., Egistelli, L., Eufemi, M., d'Abusco, A.S., Altieri, F., Lascu, I., Turano, C. and Giartosio, A. (2006). DNA sequences acting as binding sites for NM23/NDPK proteins in melanoma M14 cells. J. Cell Biochem., 98, 421-428
37. Michelotti, E.F., Sanford, S., Freije, J.M., MacDonald, N.J., Steeg, P.S. and Levens, D. (1997). Nm23/PuF does not directly stimulate transcription through the CT element in vivo. J. Biol. Chem., 272, 22526-22530
38. Hildebrandt, M., Lacombe, M.L., Mesnildrey, S. and Veron, M. (1995). A human NDP-kinase B specifically binds single-stranded poly-pyrimidine sequences. Nucleic Acids Res., 23, 3858-3864
39. Zheng, L., Roeder, R.G. and Luo, Y. (2003). S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component. Cell, 114, 255-266
40. Rayner, K., Chen, Y.X., Hibbert, B., White, D., Miller, H., Postel, E.H. and O'Brien, E.R. (2008). Discovery of NM23-H2 as an estrogen receptor beta-Associated protein: role in estrogen-induced gene transcription and cell migration. J. Steroid Biochem. Mol. Biol., 108, 72-81
41. Gross, C., Dubois-Pot, H. and Wasylyk, B. (2008). The ternary complex factor Net/Elk-3 participates in the transcriptional response to hypoxia and regulates HIF-1 alpha. Oncogene, 27, 1333-1341
42. Kim, Y.S., Kang, H.S. and Jetten, A.M. (2007). The Kruppel-like zinc finger protein Glis2 functions as a negative modulator of the Wnt/beta-catenin signaling pathway. FEBS Lett., 581, 858-864